|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 欧洲新生儿呼吸窘迫综合征防治指南-2010版显示文摘呼吸窘迫综合征(RDS)是由于肺表面活性物质(PS)缺乏及肺结构发育不成熟所致,多见于早产儿,自然病程为生后当时或很快发病,并在生后2d内进行性恶化,如不及时治疗,因进行性缺氧和呼吸衰竭而死亡,存活者,在生后2—4d病情开始改善。胎龄越小,RDS发生率越高,2006年EuroNeoStat的数据显示:胎龄23~25周的早产儿RDS发生率为91%, | Sweet DG Carnielli V Greisen G Hallman M Ozek E Plavka R Saugstad OD Simeoni U Speer CP Halliday HL 袁琳(翻译) 陈超(审校) | 2011 | 中华儿科杂志2011，49，1： | 137 |
| 2 | 血管性认知障碍的诊断标准:国际血管性行为与认知障碍学会的申明显示文摘长期以来,脑血管病(CVD)就被认为是认知损害的一个重要原因,但是有关脑血管病后认知障碍的概念化却有着一段多变的历史。'动脉变硬'或脑的动脉粥样硬化是'老化'的原因,是存在已久的观点,在20世纪60年代受到了来自英格兰纽卡斯尔的神经病理学研究的质疑。这些研究表明,血管性痴呆(vascular dementia,Va D)与超过一定程度的多发性脑梗死有关。 | 徐岩 郭起浩 Sachdev P Kalaria R O'Brien J Skoog I Alladi S Black SE Blacker D Blazer DG Chen C Chui H Ganguli M Jellinger K Jeste DV Pasquier F Paulsen J Prins N Rockwood K Roman G Scheltens P | 2014 | 神经病学与神经康复学杂志2014，11，3： | 19 |
| 3 | 血管紧张素Ⅱ诱导的高血压所引起的T淋巴细胞活化与血管炎症的中枢和外周机制显示文摘研究者先前就发现,T淋巴细胞对血管紧张素Ⅱ(AngiotensinⅡ,AngⅡ)诱导的高血压的发生发展是必需的,但是,高血压发生过程中的T细胞活化机制尚不明确。该文研究者探讨了中枢神经系统和血压升高在AngⅡ导致的T细胞活化与血管炎症中的作用。 | 张玲玉 叶鹏 Marvar PJ Thabet SR Guzik TJ Lob HE McCann LA Weyand C Gordon FJ Harrison DG | 2010 | 中华高血压杂志2010，18，12： | 15 |
| 4 | 译文:核心指标集研制标准:COS-STAD推荐显示文摘背景核心指标集(Core Outcome Set,COS)的应用是为确保研究人员测量并报告那些与其研究最可能相关的结局指标。目前,已开展数百个COS研究,但还没有对这些研究进行正式的质量评价。核心指标集研制标准(Core Outcome Set-STAndards for Development,COS-STAD)项目目的是制定国际工作组公认的COS研究最低设计标准,而对于COS研究的最终报告还有其他具体指南:COS-STAR(Core Outcome Set-STAndards for Reporting,COS-STAR)。方法与结果一个由经验丰富的COS研制者、方法学家、期刊编辑、COS潜在使用者(临床试验员、系统评价员和临床指南制定者)及患者代表组成的国际组织制定了COS-STAD推荐,用以帮助改善COS的研制质量,并为判断已经形成的COS所采用的方法是否恰当提供评估支撑。通过公开的专家问卷调查产生了一份初始条目清单,并经两轮德尔菲(Delphi)问卷调查优化,共有近250名来自关键利益相关方的代表参加。参与者使用一个1~9分的量表为每个条目的重要性打分。某个条目可以进入到最低标准集合的共识原则是,每个相关方的投票参与者中至少有70%对该条目打分为7~9分。德尔菲调查之后,还要与代表多个相关方的研究管理组进行共识讨论。COS-STAD包含11条最低标准,是所有COS研究项目的最低设计建议规范。本推荐重点包括3个关键领域:范围、相关方和共识过程。结论 COS-STAD项目确立了11条最低标准,供COS研制者设计研究项目和COS使用者判断已形成的COS研究方法学是否应用合理。 | 张明妍(译) 张俊华(译) 杜亮(译) 张永刚(译) 杨丰文(译) 冯睿(译) 季昭臣(译) Kirkham JJ Davis K Altman DG | 2018 | 中国循证医学杂志2018，18，7： | 15 |
| 5 | The effect of retinoic acid on Ito cell proliferation and content of DNA and RNA显示文摘 | Gao ZL Li DG Lu HM Gu XH | 1999 | World Journal of Gastroenterology1999，5，5： | 13 |
| 6 | Isolation and Structure Elucidation of Autolytimycin, A New Compound Produced by Streptomyces Autolyticus JX-47显示文摘Autolytimycin 1 was isolated from the culture filtrate of Streptomyces autolyticus JX-47, together with two known compounds, lebstatin 2 and 17-O-demethyl-geldanamycin 3. These compounds showed the activities of anti-HSV-I. The structure of 1 was determined by spectral analysis. | Li, MG Wu, SH Zhao, LX Zhang, Q Li, WJ Cui, XL Xu, LH Wu, DG Jiang, CL | 2001 | Chinese Chemical Letters2001，12，10： | 10 |
| 7 | 干扰素调节因子5通过损伤胞葬作用控制动脉粥样硬化病变中的坏死核心形成显示文摘髓系细胞是动脉粥样硬化病变发展和易损斑块形成的核心。动脉吞噬细胞吸收凋亡细胞(胞葬作用)的能力受损,可促进病变生长并建立坏死核心。干扰素调节因子(interferon regulatory factor,IRF)5是髓系细胞功能的重要调节因子。该研究试图确定IRF5是否影响动脉粥样硬化病变的形成和表型。方法:通过两种互补模型,研究IRF5在动脉粥样硬化中的作用: | Seneviratne AN Edsfeldt AO Cole JE Kassiteridi C Swart M Park I Green P Khoyratty TE Saliba DG Goddard ME Sansom SN Goncalves I Krams R Udalova IA Monaco C 刘莉 叶鹏 | 2017 | 中华高血压杂志2017，25，8： | 9 |
| 8 | 4℃储存皮肤的最佳条件显示文摘 | 朱兆明 Ritc.,DG | 1989 | 中华外科杂志1989，27，3： | 8 |
| 9 | RTOG 0211:a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients显示文摘PURPOSE: To determine the safety and efficacy of gefitinib,an epidermal growth factor receptor(EGFR) tyrosine kinase inhibitor,in combination with radiation for newly diagnosed glioblastoma(GBM) patients.METHODS AND MATERIALS: Between March 21,2002,and May 3,2004,Radiation Therapy Oncology Group(RTOG) 0211 enrolled 31 and 147GBM patients in the phase 1 and 2 arms,respectively.Treatment consisted of daily oral gefinitnib started at the time of conventional cranial radiation therapy(RT) and continued post RT for 18 months or until progression.Tissue microarrays from 68 cases were analyzed for EGFR expression.RESULTS: The maximum tolerated dose(MTD) of gefitinib was determined to be 500 mg in patients on non-enzyme-inducing anticonvulsant drugs(non-EIAEDs).All patients in the phase 2 component were treated at a gefitinib dose of 500 mg;patients receiving EIADSs could be escalated to 750 mg.The most common side effects of gefitinib in combination with radiation were dermatologic and gastrointestinal.Median survival was 11.5 months for patients treated per protocol.There was no overall survival benefit for patients treated with gefitinib + RT when compared with a historical cohort of patients treated with RT alone,matched by RTOG recursive partitioning analysis(RPA) class distribution.Younger age was significantly associated with better outcome.Per protocol stratification,EGFR expression was not found to be of prognostic value for gefitinib + RT-treated patients.CONCLUSIONS: The addition of gefitinib to RT is well tolerated.Median survival of RTOG 0211 patients treated with RT with concurrent and adjuvant gefitinib was similar to that in a historical control cohort treated with radiation alone. | Chakravarti A Wang M Robins HI Lautenschlaeger T Curran WJ Brachman DG Schultz CJ Choucair A Dolled-Filhart M Christiansen J Gustavson M Molinaro A Mischel P Dicker AP Bredel M Mehta M | 2013 | 中国神经肿瘤杂志2013，11，1： | 8 |
| 10 | A CLASS OF MODIFIED BROYDEN ALGORITHMS显示文摘In this paper we discuss the convergence of the modified Broyden algorithms.We prove that the algorithms are globally convergent for the colltinuous differen tiable function and the rate of convergence of the algorithms is one-step superlinear and n-step second-order for the uniformly convex objective function. From the dis-cussion of this paper, we may get some convergence properties of the Broyden | PU, DG TIAN, WW | 1994 | Journal of Computational Mathematics1994，12，4： | 6 |
| 11 | 随机对照试验中的患者报告结局:CONSORT PRO扩展版显示文摘临床试验报告规范CONSORT(Consolidated Standards of Reporting Trials,CONSORT)声明旨在提高随机对照试验(randomized controlled trail,RCT)的报告质量,然而该声明却缺少专门关于患者报告结局(patient-reported outcomes,PROs)的指引,而这部分内容恰恰也是临床试验经常报告不足的内容。患者报告结局指标数据的缺失影响了临床试验结果的价值。本文报告了依据'提高医疗卫生研究的质量和透明度协作网'(EQUATOR Network)所提出的报告规范研发方法学框架制定的临床试验报告规范—CONSORT患者报告结局扩展版(CONSORT PROs)。最终推荐5个CONSORT患者报告结局清单条目,用于以患者报告结局为主要或关键的次要结局指标的随机对照试验。这些推荐条目强烈要求:(1)在摘要中需明确说明将患者报告结局作为主要或次要结局指标;(2)提供针对患者报告结局指标及其相关适用范畴的假设(如是否使用了多维度患者报告结局指标的检测工具);(3)提供或引用患者报告结局测量工具效度和信度的证据;(4)明确说明处理缺失数据的统计学方法;(5)讨论以患者报告结局指标为研究结果指标的特定局限性和结果对其他人群和临床实践的影响。本文还提供了相关条目的示例和附有患者报告结局的CONSORT流程图。建议在报告以患者报告结局作为主要结局指标或关键的次要结局指标时,以CONSORT患者报告结局扩展版与原版的CONSORT报告规范相互参考进行报告。改进后的患者报告结局试验数据将大大促进对随机对照试验结果的全面解释,并较好指导患者的治疗。 | 陈泽(翻译) 陈珏璇(翻译) 段玉婷(翻译) 张弛(回译) 陈耀龙(审校) 卞兆祥(翻译) Calvert M Blazeby J Altman DG | 2021 | 中国循证医学杂志2021，21，3： | 5 |
| 12 | 心房肽:一种有临床实用意义的激素显示文摘ANP为一28个氨基酸的多肽,由冠状窦分泌,正常人基础浓度为10~70pg/ml。已认识的两种心房肽均有利钠、利尿作用。心房肽Ⅰ选择性松弛肠道平滑肌,心房肽Ⅱ则对血管和肠道平滑肌均有松弛作用。ANP主要以下述4种方式拮抗肾素—血管紧张素—醛固酮系统的作用:①使血管舒张;②通过肾上腺皮质阻滞醛固酮分泌; | Birney MH Denney DG 杨振东 | 1991 | 国外医学(内分泌学分册)1991，11，1： | 3 |
| 13 | 肥厚性心肌病心力衰竭患者左室流出道压差和心房功能研究显示文摘目的通过彩色Doppler超声心动图评价左室射血分数正常的心肌肥厚心力衰竭患者左室流出道(LVOT)压差及心房功能的变化。方法选择52例正常人作为正常组,53例无梗阻型肥厚性心肌病心力衰竭患者作为无梗阻组,66例梗阻型肥厚性心肌病心力衰竭患者作为梗阻组,其中128例进行多巴酚丁胺负荷脉冲型、连续波型彩色多普勒超声心动图检查。测定3组LVOT压差及左房内径。结果无梗阻组和梗阻组患者左室短轴内径明显小于正常组,梗阻组LVOT压差较无梗阻组明显增加,心房内径明显增大,A峰明显增高,2组比较均有显著性差异(P均<0.05);E/A比值3组间比较无显著性差异。结论 LVOT梗阻型肥厚性心肌病心力衰竭患者心房功能明显改变,负荷超声、心房功能评价有助于评价梗阻型肥厚性心肌病心力衰竭患者LVOT压差和心房功能。 | 周清华 Gibson DG | 2014 | 现代中西医结合杂志2014，23，32： | 3 |
| 14 | Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in mice显示文摘AIM: To study the relative efficacy of cisapride,metoclopramide, domperidone, erythromycin and mosapride on gastric emptying (GE) and small intestinal transit (SIT)in morphine treated mice.METHODS: Phenol red marker meal was employed to estimate GE and SIT in Swiss albino mice of either sex. The groups included were control, morphine 1 mg/kg (s.c. 15min before test meal) alone or with (45 min before test meal p.o.) cisapride 10 mg/kg, metoclopramide 20 mg/kg,domperidone 20 mg/kg, erythromycin 6 mg/kg and mosapride 20 mg/kg.RESULTS: Cisapride, metoclopramide and mosapride were effective in enhancing gastric emptying significantly (P<0.001)whereas other prokinetic agents failed to do so in normal mice. Metoclopramide completely reversed morphine induced delay in gastric emptying followed by mosapride.Metoclopramide alone was effective when given to normal mice in increasing the SIT. Cisapride, though it did not show any significant effect on SIT in normal mice, was able to reverse morphine induced delay in SIT significantly (P<0.001)followed by metoclopramide and mosapride.CONCLUSION: Metoclopramide and cisapride are most effective in reversing morphine-induced delay in gastric emptying and small intestinal transit in mice respectively. | AD Suchitra SA Dkhar DG Shewade CH Shashindran | 2003 | World Journal of Gastroenterology2003，9，4： | 3 |
| 15 | A New Ursene Type Triterpenoid from Crepis napifera显示文摘A new triterpenoid, urs-20-en-3β-acetoxy-22α-ol, and three known compounds 3β- acetoxy-amyrin, 3β-acetoxy-lupeol, lupeol were isolated from the leaves of Crepis napifera (Franch.) Babc. Their structures were determined by means of spectroscopic studies. | Wu, SH Luo, XD Ma, YB Wu, DG | 2000 | Chinese Chemical Letters2000，11，8： | 3 |
| 16 | 双心室起搏与右心室起搏对充血性心力衰竭急性心功能的影响显示文摘目的最近研究提示心脏再同步治疗有效地改善了慢性心肌病心力衰竭患者心功能。本研究旨在探讨双心室和右心室起搏对心功能的相对影响。方法 15例慢性心力衰竭患者心功能Ⅲ级,左心室射血分数<35%,QRS>130ms和二尖瓣反流。安装心房-双心室再同步起搏器。彩色多普勒超声心动图观察心功能变化。结果急性双心室和右心室起搏并未影响左心室内径和短轴缩短率,也不影响左心室射血速度和排血量。左心室压力上升和下降峰速率无明显变化。等容收缩时间缩短(P<0.05),但不影响等容舒张时间。增加Z比例(P<0.05)。缩短二尖瓣反流时间(P<0.05),对二尖瓣环和三尖瓣环运动幅度和峰速率无明显影响。双心室和右心室起搏之间无明显差别。结论双心室起搏改善了慢性心肌病心功能。双心室和右心室起搏无明显差别。双心室起搏是一种有前途的心脏再同步治疗方法。 | 周清华 Gibson DG | 2010 | 中华临床医师杂志(电子版)2010，4，8： | 3 |
| 17 | 显示文摘 | Yu DG Kimura Y Tomita Y | 2000 | Clin-Laser-Med-Surg2000，18，1： | 2 |
| 18 | Three-dimensional object recognition from single two-dimensional images显示文摘 | Lowe DG | 1987 | Artificial Intelligence1987，31，7： | 2 |
| 19 | Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans显示文摘 | Mitchell DG Kim I Chang TS | 1991 | Investigative Radiology1991，26，12： | 2 |
| 20 | 新产品开发小组的边界管理显示文摘 | 安柯.,DG 吴贵生 | 1995 | 中外科技政策与管理1995，，12： | 2 |
您所在的机构暂未开通此部分的功能，请联系管理员